Category:acidity regulators, firming agents, sequestrants, nutrient supplements, flavor enhancer
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:
Google Scholar: | Search |
Google Books: | Search |
Google Scholar: with word "volatile" | Search |
Google Scholar: with word "flavor" | Search |
Google Scholar: with word "odor" | Search |
Perfumer and Flavorist: | Search |
Google Patents: | Search |
US Patents: | Search |
EU Patents: | Search |
Pubchem Patents: | Search |
PubMed: | Search |
NCBI: | Search |
| FDA/DG SANTE Petitions, Reviews, Notices: |
184.1199 | Calcium gluconate View - review |
GRN 136 | Calcium gluconate View - notice PDF |
582.6219 | Calcium gluconate View - review |
EU SANCO | Calcium gluconate View - review |
JECFA Food Additive: | Calcium Gluconate |
GSFA Codex: | Calcium gluconate (578) |
DG SANTE Food Additives: | calcium gluconate |
FDA Mainterm (SATF): | 299-28-5 ; CALCIUM GLUCONATE |
FDA Regulation: | FDA PART 150 -- FRUIT BUTTERS, JELLIES, PRESERVES, AND RELATED PRODUCTS Subpart B--Requirements for Specific Standardized Fruit Butters, Jellies, Preserves, and Related Products Sec. 150.141 Artificially sweetened fruit jelly.
FDA PART 150 -- FRUIT BUTTERS, JELLIES, PRESERVES, AND RELATED PRODUCTS Subpart B--Requirements for Specific Standardized Fruit Butters, Jellies, Preserves, and Related Products Sec. 150.161 Artificially sweetened fruit preserves and jams.
FDA PART 184 -- DIRECT FOOD SUBSTANCES AFFIRMED AS GENERALLY RECOGNIZED AS SAFE Subpart B--Listing of Specific Substances Affirmed as GRAS Sec. 184.1199 Calcium gluconate.
|
Physical Properties:
Appearance: | white crystalline powder (est) |
Assay: | 98.00 to 100.00
|
Food Chemicals Codex Listed: | No |
Melting Point: | 195.00 °C. @ 760.00 mm Hg
|
Boiling Point: | 673.00 to 674.00 °C. @ 760.00 mm Hg
|
Flash Point: | 707.00 °F. TCC ( 375.00 °C. )
|
logP (o/w): | -3.175 (est) |
Soluble in: |
| water, 3.33E+04 mg/L @ 25 °C (exp) |
Insoluble in: |
| alcohol |
Organoleptic Properties:
Odor Description:at 100.00 %. odorless |
Odor and/or flavor descriptions from others (if found). |
Cosmetic Information:
Suppliers:
Safety Information:
Preferred SDS: View |
|
Hazards identification |
|
Classification of the substance or mixture |
GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) |
None found. |
GHS Label elements, including precautionary statements |
|
Pictogram | |
|
Hazard statement(s) |
None found. |
Precautionary statement(s) |
None found. |
Oral/Parenteral Toxicity: |
intravenous-dog LDLo 1987 mg/kg Journal of Pharmacology and Experimental Therapeutics. Vol. 47, Pg. 183, 1933.
intravenous-guinea pig LDLo 1810 mg/kg GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS
LUNGS, THORAX, OR RESPIRATION: DYSPNEA
CARDIAC: OTHER CHANGES Archives Internationales de Pharmacodynamie et de Therapie. Vol. 191, Pg. 44, 1971.
intraperitoneal-mouse LD50 2200 mg/kg Journal of Drug Research. Vol. 15(1-2), Pg. 121, 1984.
intravenous-mouse LD50 950 mg/kg Toxicology and Applied Pharmacology. Vol. 4, Pg. 492, 1962.
oral-mouse LDLo 10000 mg/kg Farmaco, Edizione Pratica. Vol. 26, Pg. 144, 1971.
intravenous-rat LD50 950 mg/kg Drugs in Japan Vol. 6, Pg. 226, 1982.
oral-rat LDLo 10000 mg/kg Farmaco, Edizione Pratica. Vol. 26, Pg. 144, 1971.
|
Dermal Toxicity: |
subcutaneous-mouse LD50 2890 mg/kg Journal of the American Pharmaceutical Association, Scientific Edition. Vol. 45, Pg. 47, 1956.
|
Inhalation Toxicity: |
Not determined
|
Safety in Use Information:
Category: | acidity regulators, firming agents, sequestrants, nutrient supplements, flavor enhancer |
Recommendation for calcium gluconate usage levels up to: | | not for fragrance use.
|
|
Safety References:
References:
| calcium (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoate |
NIST Chemistry WebBook: | Search Inchi |
Canada Domestic Sub. List: | 299-28-5 |
Pubchem (cid): | 9290 |
Pubchem (sid): | 134975115 |
Other Information:
(IUPAC): | Atomic Weights of the Elements 2011 (pdf) |
Videos: | The Periodic Table of Videos |
tgsc: | Atomic Weights use for this web site |
(IUPAC): | Periodic Table of the Elements |
FDA Substances Added to Food (formerly EAFUS): | View |
CHEBI: | View |
CHEMBL: | View |
KEGG (GenomeNet): | C08133 |
HMDB (The Human Metabolome Database): | Search |
FooDB: | FDB001981 |
Export Tariff Code: | 2940.00.6000 |
FDA Listing of Food Additive Status: | View |
ChemSpider: | View |
Wikipedia: | View |
Formulations/Preparations: •calcium gluconate, usp contains 9% calcium available as calcium gluconate tablets, usp, containing 325, 500, 650, or 1000 mg of the salt for im and iv injection, calcium gluconate injection, usp, admin as 10% soln (0.45 meq ca++ml).
•grades: technical; usp; fcc; special for ampules.
•due to its limited solubility, calcium gluconate must frequently be suspended in liquid mixtures and tragacanth is useful as a suspending agent.
•calcium gluconate injection:a 10% soln; 9.3 mg of ca+2ml 10-ml vial
|
Potential Blenders and core components note
Potential Uses:
Occurrence (nature, food, other): note
Synonyms:
| calcicol | | calciofon | | calcipur | | calcium (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoate | | calcium bis(D-gluconate) | | calcium bis[(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoate] | | calcium di-D-gluconate monohydrate | | calcium di-dextro-gluconate monohydrate | | calcium di(D-gluconate) | | calcium gluconate anhydrous | | calcium gluconate anhydrous USP FCC powder | | calcium gluconate monohydrate USP FCC fine granular | | calcium gluconate monohydrate USP FCC granular | | calcium gluconate monohydrate USP FCC powder | | calcium gluconate, anhydrous USP | | calcium gluconate, monohydrate USP | | calcium hexagluconate | | calciumgluconate | | calglucol | | dragocal | | ebucin | | glucal | | glucobiogen | | gluconic acid calcium salt | D- | gluconic acid calcium salt | D- | gluconic acid calcium salt (2:1) | dextro- | gluconic acid calcium salt (2:1) | D- | gluconic acid, calcium salt (2:1) | | kalpren | | novocal |
Articles:
PubMed:Aluminum Contamination in Parenteral Nutrition Admixtures for Low-Birth-Weight Preterm Infants in Mexico. |
J-Stage:Evaluation of the Suppressive Effect on Bitter Taste of Gluconate |
PubMed:Postprandial metabolic responses of serum calcium, parathyroid hormone and C-telopeptide of type I collagen to three doses of calcium delivered in milk. |
PubMed:Spontaneous supersaturation of calcium D-gluconate during isothermal dissolution of calcium L-lactate in aqueous sodium D-gluconate. |
PubMed:Enhanced glucagon-like peptide-1 secretion in a patient with glucagonoma: implications for glucagon-like peptide-1 secretion from pancreatic α cells in vivo. |
PubMed:Aqueous solubility of calcium L-lactate, calcium D-gluconate, and calcium D-lactobionate: importance of complex formation for solubility increase by hydroxycarboxylate mixtures. |
PubMed:Effect of calcium on the kinetics of free fatty acid release during in vitro lipid digestion in model emulsions. |
PubMed:Safety and efficacy of polycalcium for improving biomarkers of bone metabolism: a 4-week open-label clinical study. |
PubMed:A single-dose study of denosumab in patients with various degrees of renal impairment. |
PubMed:Amlodipine fatality in an infant with postmortem blood levels. |
PubMed:Feasibility of using dialysis for determining calcium ion concentration and pH in calcium-fortified soymilk at high temperature. |
PubMed:Drug shortage. |
PubMed:Aluminium exposure from parenteral nutrition in preterm infants and later health outcomes during childhood and adolescence. |
PubMed:Hormone replacement after thyroid and parathyroid surgery. |
PubMed:Calcium and phosphate compatibility in low-osmolarity parenteral nutrition admixtures intended for peripheral vein administration. |
PubMed:Intravenous ceftriaxone and calcium in the neonate: assessing the risk for cardiopulmonary adverse events. |
PubMed:High altitude induced anorexia: effect of changes in leptin and oxidative stress levels. |
PubMed:Silicate release from glass for pharmaceutical preparations. |
PubMed:Primary periodic paralyses. |
PubMed:[Zinc and copper content in individual components used to prepare pediatric total nutrition mixtures]. |
PubMed:Calcium supplementation in clinical practice: a review of forms, doses, and indications. |
PubMed:The role of oxalate in star fruit neurotoxicity of five-sixths nephrectomized rats. |
PubMed:Reaction on D-glucal by an inverting phosphorylase to synthesize derivatives of 2-deoxy-beta-D-arabino-hexopyranosyl-(1-->4)-D-glucose (2II-deoxycellobiose). |
PubMed:Arsenic species in solutions for parenteral nutrition. |
PubMed:[A case of intraoperative hyperkalemia induced with administration of an angiotensin II receptor antagonist (AIIA) and intake of dried persimmons]. |
PubMed:Incorporation of a high concentration of mineral or vitamin into chitosan-based films. |
PubMed:Fluid and electrolyte therapy in ruminants. |
PubMed:A fortifier comprising protein, vitamins, and calcium-glycerophosphate for preterm human milk. |
PubMed:[The evaluation of the efficiency of biological prophylaxis of lead poisoning (experimental study)]. |
PubMed:Acute effects of calcium sodium citrate supplementation of a test meal on mineral homeostasis, oxalate, and calcium oxalate crystallization in the urine of healthy humans--preliminary results in patients with idiopathic calcium urolithiasis. |
PubMed:Anything else to add? |
PubMed:Parenteral calcium gluconate supplementation: efficacious or potentially disastrous? |
PubMed:The study of a physiological significance of prolactin in the regulation of calcium metabolism during pregnancy and lactation in rats. |
PubMed:Chromium and zinc contamination of parenteral nutrient solution components commonly used in infants and children. |
PubMed:Calcium and phosphate solubility curves for parenteral nutrient solutions containing Vaminolact. |
PubMed:Evaluation of four animal models of intrarenal calcium deposition and assessment of the influence of dietary supplementation with essential fatty acids on calcification. |
PubMed:Effects of meal on the pharmacokinetics of fluoride from oral monofluorophosphate. |
PubMed:Influence of dietary calcium and vitamin D on colon epithelial cell proliferation and 1,2-dimethylhydrazine-induced colon carcinogenesis in rats fed high fat diets. |
PubMed:Hypocalcemia and pregnancy-induced hypertension produced by maternal fasting. |
PubMed:Glycero- vs glucose-phosphate in parenteral nutrition of premature infants: a comparative in vitro evaluation of calcium/phosphorus compatibility. |
PubMed:Effect of dietary calcium on colon carcinogenesis induced by a single injection of 1,2-dimethylhydrazine in rats. |
PubMed:Secondary copper deficiency in cattle caused by molybdenum contamination of fodder: a case history. |
PubMed:Parturient paresis and hypocalcemia in ruminant livestock. |
PubMed:Gastrointestinal absorption of calcium from milk and calcium salts. |
PubMed:The effect of long-term enrichment of diet with selenium, vitamin E and B15 on the activity of certain enzymes in rat brain. |
PubMed:Calcium and phosphate solubility in neonatal parenteral nutrient solutions containing Aminosyn PF. |
PubMed:Calcium and phosphate solubility in neonatal parenteral nutrient solutions containing TrophAmine. |
PubMed:The effect of vitamin and mineral supplements and health foods on physical endurance and performance. |
PubMed:Hydrofluoric acid skin treatment not approved by FDA. |
PubMed:Effect of long-term diet enrichment with selenium, vitamin E and vitamin B15 on the degree of fatty infiltration of the liver. |
PubMed:Calcium and phosphorus in neonatal parenteral nutrition solutions. |
PubMed:The early diagnosis of gastrinoma. |
PubMed:Nutritional rickets due to food fadism. |
PubMed:[Effect of methionine and vitamins B12 and B15 on the content and distribution of proteins, glycogen and lipids in the hepatic lobules of chickens]. |
PubMed:FDA's hands loosely tied. |
PubMed:Vitamin B15--whatever it is, it won't help. |
PubMed:From those wonderful people who brought you laetrile. |
PubMed:[Dynamic aspects of blood gastrin after antral stimulation]. |
|
the calcium salt of gluconic acid. the compound has a variety of uses, including its use as a calcium replenisher in hypocalcemic states. Food additive: firming agent, sequestrant, stabiliser, texturiser. Anticaking agent in powdered coffee
Calcium gluconate is a mineral supplement. It is the form of calcium most widely used in the treatment of hypocalcemia. Calcium gluconate contains 9.3% calcium. It is also used to counteract an overdose of magnesium sulfate, often administered to pregnant women experiencing premature labor to slow or stop contractions. Excess magnesium sulfate can cause respiratory depression, for which calcium gluconate would be the antidote.
|